Search results

Back
1 - 10 of 254 Search results
 -  04 July 2018

 -  04 July 2018

Ipsen announces CELESTIAL phase 3 pivotal trial results in the New England Journal of Medicine

...

 -  19 July 2018

 -  19 July 2018

Ipsen and BioLabs to open new Innovation Center in Cambridge (U.S.) to foster development of new therapies for patients

Ipsen Innovation Center – BioLabs to be located in Ipsen’s new and third global hub in the heart of Cambridge, Massachusetts...

 -  17 May 2018

 -  17 May 2018

European Commission approves Ipsen’s Cabometyx® (cabozantinib) for the first-line treatment of adults with intermediate- or poor- risk advanced renal cell carcinoma 

...

 -  17 May 2018

 -  17 May 2018

La Commission européenne approuve Cabometyx® (cabozantinib) d’Ipsen en traitement de première ligne des adultes atteints d’un cancer du rein avancé à risque intermédiaire ou élevé 

...

1 … 24 25 26